Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma Liver”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06254248
What this trial is testing

Safety of Atezolizumab-Bevacizumab in Liver Transplanted Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Liver TransplantHepatocellular Carcinoma RecurrentSystemic Treatment
Assistance Publique - Hôpitaux de Paris 50
Not applicableStudy completedNCT01528878
What this trial is testing

Safety, Efficacy, and Dosing of Stereotactic Radiosurgery for Hepato-cellular Carc/Colo-rectal Liver Metastases

Who this might be right for
Liver NeoplasmsColonic NeoplasmsMetastatic Cancer to Liver
UNC Lineberger Comprehensive Cancer Center 30
Post-approval studies (Phase 4)UnknownNCT01102335
What this trial is testing

Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using Transcatheter Arterial Chemoembolization (TACE) With Anti-hepatitis B Virus (Anti-HBV) Therapy

Who this might be right for
Hepatocellular Carcinoma
Fudan University 80
Testing effectiveness (Phase 2)Study completedNCT03781934
What this trial is testing

Evaluate MIV-818 in Patients With Liver Cancer Manifestations

Who this might be right for
Hepatocellular CarcinomaIntrahepatic CholangiocarcinomaLiver Metastases
Medivir 53
Testing effectiveness (Phase 2)Active Not RecruitingNCT05319431
What this trial is testing

A Phase II Study of AK104 Plus Lenvatinib and TACE in HCC

Who this might be right for
Unresectable, Non-metastatic Hepatocellular Carcinoma
Akeso 60
Not applicableUnknownNCT05614466
What this trial is testing

The SIMPLY-B Study

Who this might be right for
Hepatitis B Virus Related Hepatocellular Carcinoma
Nadine Barnes 100
Testing effectiveness (Phase 2)Looking for participantsNCT07560566
What this trial is testing

SHIELD: Sorafenib Hand-foot Syndrome Inhibition With Pre-Emptive Local Delivery of Topical Indomethacin

Who this might be right for
Hepato Cellular Carcinoma (HCC)Hand Foot Skin Syndrome
National Taiwan University Hospital 39
Large-scale testing (Phase 3)UnknownNCT04667351
What this trial is testing

HAIC of Oxaliplatin, and 2400 mg/m² 5-fu vs HAIC of Oxaliplatin, and 1200 mg/m² 5-fu for Unresectable HCC: a Randomised Phase 3 Non-inferiority Trial

Who this might be right for
HepatoCellular Carcinoma
Sun Yat-sen University 400
Not applicableUnknownNCT05650151
What this trial is testing

Peri-operative Vitamin D Therapy for Hepatectomy

Who this might be right for
Vitamin D DeficiencyHepatocellular CarcinomaPerioperative Complication
National Taiwan University Hospital 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07537777
What this trial is testing

Benmelstobart Plus Anlotinib Combined With SBRT for Patients With Hepatocellular Carcinoma Failing First-Line Targeted Therapy

Who this might be right for
Hepatocellular Carcinoma (HCC)First-line Targeted Therapy FailureOligometastatic Hepatocellular Carcinoma+3 more
Nanfang Hospital, Southern Medical University 29
Not applicableUnknownNCT01957241
What this trial is testing

PLA for HCC and Esophageal ca Serum

Who this might be right for
Hepatocellular CarcinomaEsophageal Cancer
National Taiwan University Hospital 164
Not applicableUnknownNCT02564666
What this trial is testing

The Effect of Telephone Counseling on the Compliance and Satisfaction for Advanced HCC Patients Receiving Sorafenib

Who this might be right for
Hepatocellular Carcinoma
Asan Medical Center 64
Very early researchStudy completedNCT05250895
What this trial is testing

BOLD MRI and FMISO PET for the Assessment of Hypoxic Tumor Microenvironment in Patients with Oligometastatic Liver Cancer Undergoing Yttirum-90 Selective Internal Radiation Therapy

Who this might be right for
BCLC Stage a Hepatocellular CarcinomaBCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular Carcinoma+1 more
Emory University 9
Early research (Phase 1)Study completedNCT04418401
What this trial is testing

Study on the Safety and Efficacy of Donafinib Combined With Anti-PD-1 Antibody as Adjuvant Therapy for HCC Patients

Who this might be right for
Hepatocellular Carcinoma
Zhejiang University 30
Large-scale testing (Phase 3)Study completedNCT05016245
What this trial is testing

MANDARIN (S6371)

Who this might be right for
Inoperable Hepatocellular Carcinoma
Boston Scientific Corporation 92
Not applicableLooking for participantsNCT06621472
What this trial is testing

Retrolaminar Block Versus Subcostal Transversus Abdominis Plane Block in Liver Resection Surgery

Who this might be right for
Cancer Liver
Cairo University 90
Not applicableStudy completedNCT00817895
What this trial is testing

Intraoperative Chemotherapy Against Hepatocellular Carcinoma Recurrence

Who this might be right for
Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 150
Testing effectiveness (Phase 2)Study completedNCT01247337
What this trial is testing

Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
Dorte Nielsen 56
Post-approval studies (Phase 4)UnknownNCT01438437
What this trial is testing

Trial of Ablation of Small Hepatocellular Carcinomas in Patients of Cirrhosis

Who this might be right for
Hepatocellular Carcinoma
All India Institute of Medical Sciences 54
Not applicableLooking for participantsNCT04410302
What this trial is testing

Patient-Derived Xenografts to Reduce Cancer Health Disparities

Who this might be right for
Bladder CarcinomaGastric CarcinomaLiver and Intrahepatic Bile Duct Carcinoma+2 more
University of California, Davis 500
Next Page